HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,867 | -12.8% | 32,000 | -17.2% | 0.07% | +1.5% |
Q2 2023 | $3,289 | -3.7% | 38,625 | -6.4% | 0.07% | -16.2% |
Q1 2023 | $3,416 | +55.1% | 41,278 | +47.4% | 0.08% | +29.0% |
Q4 2022 | $2,202 | -99.9% | 28,000 | +10.5% | 0.06% | +24.0% |
Q3 2022 | $1,877,000 | +74.6% | 25,350 | +53.6% | 0.05% | +56.2% |
Q2 2022 | $1,075,000 | +13.3% | 16,500 | +10.0% | 0.03% | +45.5% |
Q1 2022 | $949,000 | -0.1% | 15,004 | -16.2% | 0.02% | +4.8% |
Q4 2021 | $950,000 | -22.0% | 17,908 | +3.8% | 0.02% | -19.2% |
Q3 2021 | $1,218,000 | +21.8% | 17,255 | +15.0% | 0.03% | +18.2% |
Q2 2021 | $1,000,000 | +68.4% | 15,000 | +200.0% | 0.02% | +100.0% |
Q4 2020 | $594,000 | -33.0% | 5,000 | -50.8% | 0.01% | -54.2% |
Q3 2020 | $887,000 | -1.4% | 10,164 | +1.1% | 0.02% | -7.7% |
Q2 2020 | $900,000 | +311.0% | 10,050 | +92.9% | 0.03% | +420.0% |
Q4 2013 | $219,000 | -59.6% | 5,210 | -61.7% | 0.01% | -16.7% |
Q3 2013 | $542,000 | – | 13,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |